MedTrace Logo

Management of Acute Bronchitis With Pelargonium Sidoides Extract

NCT05916768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 332

Last updated 2026-01-16

No results posted yet for this study

Summary

The aim of our study is to conduct a pragmatic RCT meeting all required standards to evaluate the effectiveness of Pelargonium sidoides extract, EPs® 7630, in the management of acute bronchitis with or without COVID-19 in PCP practices and walk-in clinics in French-speaking Switzerland. The RCT will be preceded by a pilot phase to ensure its feasibility.

Conditions

  • Acute Bronchitis

Interventions

OTHER

Pelargonium sidoides extract EPs® 7630

Kaloba® solution, a standardized alcoholic extract obtained from the roots of Pelargonium sidoides (EPs® 7630).

OTHER

usual care

symptomatic treatments

Sponsors & Collaborators

  • University of Fribourg

    lead OTHER

Principal Investigators

  • Pierre-Yves Rodondi, Prof. · University of Fribourg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2025-04-24
Completion
2025-04-24

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916768 on ClinicalTrials.gov